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We conducted a cross-sectional, household survey in
Oakville, Ontario, where an outbreak of West Nile virus
(WNV) in 2002 led to an unprecedented number of cases
of meningitis and encephalitis. Practicing >2 personal pro-
tective behavior traits reduced the risk for WNV infection by
half.
L
ittle is known about risk factors for infection with West
Nile virus (WNV). Data about the effect of personal
protective behavior traits recommended by public health
agencies, such as wearing long sleeves and long pants,
using mosquito repellent, and avoidance of mosquito
areas, are sparse (1).
A household-based seroprevalence survey in Oakville,
Ontario, where a large outbreak of WNV occurred in the
summer of 2002, allowed us to assess modifiable risk fac-
tors for WNV infection. Oakville is located in Halton, a
region that had the highest reported incidence of clinical
WNV infection in Ontario in the 2002 season. Sixty cases
(58 confirmed and 2 probable) occurred in a population of
almost 400,000, with onset during the months of August
and September 2002 (Figure 1). Apeak in dead crow sight-
ings in Halton (600 per week) occurred 5 weeks before the
peak in human cases. Within this region, most cases
occurred in south Oakville, in the L6L and L6K forward
sortation areas (FSAs, i.e., the first 3 digits of the postal
code) (Figure 2). We hypothesized that personal protective
and source-reduction behavior would be associated with
reduced risk for WNV infection.
The Study
The survey was conducted from March to April 2003.
Households in the L6L and L6K FSAs of south Oakville
were selected with random digit dialing. Within house-
holds, a randomly selected household member >18 years
of age was invited to participate. Given that pediatric neu-
roinvasive disease is rare, children were excluded (2). The
2001 census population of these areas that was >18 years
of age was 30,467.
After verbal consent was obtained, respondents were
administered a standardized telephone survey. Survey data
were collected for respondents who resided in the study
area from July 1 to September 30, 2002. Single serum sam-
ples were collected from March 23 to June 5, 2003 (speci-
men collection was interrupted from March 29 to April 16
because of severe acute respiratory syndrome), from per-
sons who had completed the survey. Respondents were
unaware of their serologic status at the time of the tele-
phone interview, which reduced the possibility for recall
bias. Samples were collected and stored at –70°C until
they were tested. Each sample was tested with Centers for
Disease Control and Prevention WNV enzyme immunoas-
say immunoglobulin (Ig) G. Reactive samples were for-
warded to Health Canada’s National Viral Zoonotic
Laboratory in Winnipeg for plaque reduction neutraliza-
tion tests (PRNT) against West Nile, dengue, and St. Louis
encephalitis viruses (3). Since our case definition relied on
IgG, a positive result may have been caused by infection
before the outbreak. However, the prevalence would have
been low and would not likely affect our results; surveil-
lance for WNV in Ontario began in 2000, and no positive
clinical specimen was seen until the 2002 outbreak (4).
The ethics review board at McMaster University approved
the study.
Based on an assumed population of 30,500, for a preva-
lence as low as 1%, a sample of 1,500 allows for 95% con-
fidence interval (CI) from 0.5% to 1.5%, and for a
prevalence as high as 4% the sample allows 95% CI from
3% to 5%. Initially, 1,500 persons completed the survey,
but not all consented to provide a blood sample. As a
result, an additional 150 persons were surveyed in April of
2003 to achieve the required sample. Of the 1,650 persons
surveyed, 1,505 (91%) consented to provide a blood sam-
ple. This fraction represented 25% of persons initially con-
tacted about the study. No significant differences were
found in demographic characteristics, so the 2 groups were
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Figure 1. Reported human West Nile virus disease cases and
dead crow sightings in Halton Region, May to November 2002, by
epidemiology week.pooled for subsequent analysis. Because our sample did
not correspond in age to the 2001 population (Table 1), we
standardized our sample by using age-specific WNV sero-
prevalences.
To assess risk factors for WNV infection, we conduct-
ed a univariate analysis with chi-square test to assess cate-
gorical variables and Student t test to assess differences
between infected and uninfected persons. Multivariable
analysis with logistic regression was performed by using a
backwards, stepwise approach, selecting 1 variable from
each category to include in the model (indoor exposures,
outdoor exposures, personal behavior, source-reduction
behavior) if the p value was <0.10.
Forty-six (3.1% [95% CI 2.2%–4.0%]) of the 1,505
persons who provided a blood sample tested positive for
WNV IgG, which was confirmed by PRNT. Two (6%)
respondents 18–24 years of age, 7 (2%) respondents 25–44
years of age, 26 (4%) respondents 45–64 years of age, and
11 (2%) respondents >65 years of age were infected. In
addition to the 46 participants, 14 persons were positive
for WNV by IgG enzyme-linked immunosorbent assay but
were negative by PRNT. Of these, 11 showed evidence of
dengue IgG on PRNT confirmatory testing. No positive
respondent had evidence of antibodies to St. Louis
encephalitis virus on PRNTtesting. The overall estimate of
3.1% did not change based on the 2001 census after adjust-
ing for age.
Within the 2 FSAs from which the sample was drawn
were 6 patients with encephalitis (all hospitalized), 5 with
meningitis (1 hospitalized), and 8 with WNV fever (1 hos-
pitalized). The calculated rate of WNV illnesses was 47
per 100,000 population in the L6Larea and 54 per 100,000
in the L6K area (Figure 2). Cases were defined by the
attending physician’s diagnosis. No cases of meningitis or
encephalitis were seen in persons <50 years of age. Five
cases of meningitis and 1 case of encephalitis were seen in
persons 50–64 years of age; 2 cases of encephalitis were
seen among those 65–74 years, and 3 cases of encephalitis
were seen in persons >75 years. Cases were ascertained by
the Halton Region Health Department, which did epidemi-
ologic follow-up on all patients with positive WNV sero-
logic results. If we extrapolate the 2.2%–4.0% range to the
entire population of adults in the areas studied (30,467), an
estimated 670–1,219 persons were infected with WNV in
the L6L and L6K areas in the summer of 2002. The ratio
of persons with severe illness (defined as meningitis or
encephalitis) to asymptomatic or mild cases is, therefore,
1:85 (95% CI 1:60–1:110).
Results of the univariate analysis to assess modifiable
risk factors for infection are shown in Table 2. Having an
open deck or unscreened porch, time spent outside at dusk
or dawn on a work day, time spent outside at dusk or dawn
on a nonwork day, and total time spent outside on a non-
work day were associated with WNV infection. Personal
behavior associated with WNVinfection included rarely or
never avoiding areas where mosquitoes are likely to be a
problem, rarely or never avoiding going outdoors, and
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Figure 2. Calculated incidence of human West Nile virus (WNV)
cases in south Halton, 2002. The incidence was 47 cases per
100,000 in the L6L forward sortation area (FSA) and 54 cases per
100,000 in the LKL FSA.rarely or never wearing long sleeves or long pants when
outdoors. However, when >2 personal risk reduction
behavior traits were followed, the effect was protective.
The following variables were entered in the multivari-
ate model: open deck or unscreened porch, time spent out-
side at dusk or dawn on a nonwork day, and practicing >2
personal protective behavior traits. Time spent outside at
dusk or dawn on a nonwork day (adjusted odds ratio [OR]
1.47 per hour, 95% CI 1.22–1.8, p = 0.001) and practicing
>2 personal protective behavior traits (adjusted OR 0.46,
95% CI 0.25–0.84, p = 0.011) were kept in the final model.
Conclusions
We found in multivariable analysis that respondents
who practiced >2 personal protective behavior traits
(avoidance of exposure to mosquitoes, wearing long
sleeves and pants, using mosquito repellent) had ≈50%
reduction in risk of infection. We also found that time
spent outside at dusk or dawn on a nonwork day was a sig-
nificant risk factor for WNV infection, which is consistent
with findings from a previous report (1). Finding mosqui-
toes in the home was not associated with WNV infection,
as it was in a previous report (5). The seroprevalence in
Oakville in 2002 (3%) was within the range of previous
reports (1,6,7).
Given the emerging evidence on the long-term sequelae
of WNV infection (8–13), preventing WNV infection is a
public health priority. This study is the first to provide evi-
dence to support the benefit of personal protective behav-
ior in reducing risk for WNV infection.
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